,0
symbol,XFOR
price,6.44
beta,0.0
volAvg,91150
mktCap,104885704
lastDiv,0.0
range,5.38-15.0
changes,-0.19
companyName,X4 Pharmaceuticals Inc
currency,USD
cik,0001501697
isin,US98420X1037
cusip,98420X103
exchange,NasdaqCM
exchangeShortName,NASDAQ
industry,Biotechnology
website,http://www.x4pharma.com/
description,"X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 15 full-time employees. The firm is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Companyâ€™s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003."
ceo,Dr. Paula Ragan
sector,Healthcare
country,US
fullTimeEmployees,58
phone,18575298300
address,955 Massachusetts Ave Ste 4
city,Cambridge
state,MASSACHUSETTS
zip,02139
dcfDiff,
dcf,17.814
image,https://financialmodelingprep.com/image-stock/XFOR.png
ipoDate,2017-11-16
defaultImage,False
